MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$23,639K
EPS
-$0.12
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-09-30
2025-03-31
Revenues
-
-
5
5
Research and development
18,655
16,192
14,960
15,827
General and administrative
7,574
8,052
5,904
5,993
Total operating expenses
26,229
24,244
20,864
21,820
Loss from operations
-26,229
-24,244
-20,859
-21,815
Interest expense
1,097
1,068
495
1
Interest income
4,526
2,901
2,426
1,545
Other income (expense), net
-25
-152
-86
15
Total other income (expense), net
3,404
1,681
1,845
1,559
Net loss before income taxes
-22,825
-22,563
-19,014
-20,256
Income tax expense (benefit)
-
-
-
-681
Net loss
-22,825
-22,563
-19,014
-19,575
Other comprehensive income - unrealized loss on short-term investments
-814
-296
23
-30
Comprehensive loss
-23,639
-22,859
-18,991
-19,605
Basic EPS
-0.12
-0.18
-0.21
-0.26
Diluted EPS
-0.12
-0.18
-0.21
-0.26
Basic Average Shares
185,443,736
124,461,818
89,418,028
75,547,746
Diluted Average Shares
185,443,736
124,461,818
89,418,028
75,547,746
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive loss
-$23,639K
Net loss
-$22,825K
Other comprehensive
income - unrealized...
-$814K
Interest income
$4,526K
Net loss before
income taxes
-$22,825K
Total other income
(expense), net
$3,404K
Interest expense
$1,097K
Other income
(expense), net
-$25K
Loss from operations
-$26,229K
Total operating
expenses
$26,229K
Research and development
$18,655K
General and
administrative
$7,574K
Buy us a coffee
Altimmune, Inc. (ALT)
Altimmune, Inc. (ALT)